Company: Morningside Healthcare Ltd. Marketed by Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine (as HCl) 75mg, 150mg. Description: Vensir XL 75mg: Peach opaque hard capsule with red radial circular bands, filled with 6 white to off-white round biconvex film coated mini tablets. Vensir XL 150mg: Dark orange hard capsules with white [...]
Company: Eli Lilly & Co. (Ireland) Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Olanzapine (as palmoate monohydrate) 210mg, 300mg, and 405mg. After reconstitution, each 1ml suspension contains 150mg olanzapine. Description: Yellow solid powder and clear, colourless to slightly yellow solvent for prolonged release suspension for injection. Presentation: 210mg-1, €226.86; 300mg-1, €347.30; 405mg-1, €453.72. Indications: [...]
Strepsils Intensive 8.75mg lozenges provide patients with a convenient, effective and well-tolerated treatment for sore throat. Strepsils Intensive provides symptomatic relief from a sore throat by coating the throat within two minutes, dissolving in under 10 minutes and providing lasting relief for up to four hours. Strepsils Intensive is the only throat lozenge containing the [...]
AstraZeneca wish to notify MIMS Ireland’s readers that as part of a Global rationalisation process AstraZeneca is planning to withdraw the following products from the Irish market: • Avloclor 250 mg tablets • Paludrine 100mg tablets • Heminevrin Syrup and capsules • Xyloproct Ointment The following presentations from the Betaloc and Diprivan ranges are also [...]
Procter & Gamble Pharmaceuticals Ltd would like to inform you that as of 30th April 2009, they have withdrawn the marketing authorisation of Didronel (etidronate disodium) 200mg tablets from Ireland. As of 30th April 2009, they will not market or supplying Didronel 200mg tablets. However the stock remaining in circulation will be sold till the [...]
UCB (Pharma) Ireland wish to announce the cessation of marketing and supply of Pulmoclase Paediatric Syrup 100mg/5ml 250ml as of 16th April 2009. Further details may be obtained by contacting UCB (Pharma) Ireland at (01) 4637395.
Movianto would like to inform you that the manufacture of Striant SR tablets 30mg-60 has been discontinued. Movianto will cease distribution from 30th June 2009. If you have any questions regarding the discontinuation of Striant, please contact Movianto on (01) 6305413.
Loading ...
